BioSpace News Archive

Devonian Health Group Announces 2018 Annual General Shareholder’s Meeting

Shareholders should expect to receive the company’s proxy statement and related materials in early January 2019.

December 20, 2018
·
3 min read
FDA

AbbVie Submits New Drug Application to U.S. FDA and Marketing Authorization Application to EMA for Upadacitinib for Treatment of Adults with Moderate to Severe Rheumatoid Arthritis

Regulatory applications supported by robust SELECT Phase 3 program evaluating more than 4,000 patients with moderate to severe rheumatoid arthritis

December 20, 2018
·
7 min read
Drug Development

Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pfizer Inc. (NYSE: PFE) today announced that the Phase 3 ARCHES trial evaluating XTANDI®

December 20, 2018
·
14 min read
Biotech Beach

CNBC Features Medical Marijuana, Inc. as a Top 3 Largest Public CBD Company to Look at With the U.S. Farm Bill Federally Legalizing Hemp

Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage on the top national financial news network CNBC.

December 20, 2018
·
3 min read
Business

Healthy Mom And Baby Resolutions For The New Year: March Of Dimes Offers Tips For Planning A Pregnancy

For women thinking of having a baby in the coming year, making a resolution to be as healthy as possible before conception will increase the likelihood of having a healthy pregnancy and baby, says March of Dimes, the leader in the fight for moms and babies.

December 20, 2018
·
2 min read
Drug Development

Deciphera Pharmaceuticals Initiates Pivotal Phase 3 Clinical Study of Ripretinib (DCC-2618) in Second-line Patients with Gastrointestinal Stromal Tumors (“INTRIGUE” Study)

The Efficacy and Tolerability Profile of Ripretinib Will Be Compared to Sunitinib in Second-line GIST Patients Regardless of KIT or PDGFRα Mutational Status

December 20, 2018
·
8 min read
Drug Development

Phase III OLYMPUS and ROCKIES Trials for roxadustat Met Their Primary Endpoints in Chronic Kidney Disease Patients With Anemia

OLYMPUS demonstrated a statistically-significant and clinically-meaningful improvement in hemoglobin vs. placebo in non-dialysis-dependent patients

December 20, 2018
·
5 min read
Biotech Beach

MassRoots Preparing Launch of CBD Product-Focused Review and E-Commerce Platform

Aims to be a leading information portal for millions of consumers interested in CBD products; exploring E-Commerce for hemp-derived CBD products following passage of the Farm Bill

December 20, 2018
·
3 min read
Job Trends

The Growth of Non-Industrial Robotics Is Driving a Diversification of New Robotics Applications, According to Tractica

More than 100 Discrete Use Cases Are Fueling Market Growth in Enterprise, Consumer, Government, and Military Robots

December 20, 2018
·
2 min read
Business

Aquestive Therapeutics Provides End of Year Business Update, Including Progress of its Proprietary CNS Assets, Financial and Legal Matters

Projects full year 2018 revenues over $67 million, exceeding expectations, and projects end-of-year cash and cash equivalents in the range of $58 million to $60 million

December 20, 2018
·
13 min read